![Andrew Smith](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Smith
Directeur Financier/CFO chez
Sucampo Pharma Europe Ltd.
Fortune : 995 169 $ au 31/05/2026
Profil
Andrew P.
Smith was the founder of Clearlab Europe Ltd. (2001), holding the title of Finance Director (2004-2006).
Current jobs include Finance Director at Sucampo Pharma Europe Ltd. (2011-present), Director at Santhera Pharmaceuticals (USA), Inc. (present), Non-Executive Director at Arix Bioscience (2022-present), and Vice President-Operations & Finance at Sucampo GmbH (present).
Former jobs include Finance Director at 1-800 Contacts, Inc., Director at Tech Council of Maryland, Inc., Secretary & Finance Director at hVIVO Services Ltd. (2006-2009), Independent Non-Executive Director at Arix Bioscience Plc (2022-2024), Chief Financial Officer at Santhera Pharmaceuticals Holding AG (2020-2025), Chief Financial Officer at Sucampo Pharmaceuticals LLC (2011-2017), and Chief Financial & Operations Officer at Allecra Therapeutics GmbH (2017-2020).
Education includes a doctorate from the University of Durham and an undergraduate degree from Liverpool John Moores University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/12/2024 | 47 704 ( 0,32 % ) | 995 169 $ | 31/05/2026 |
Postes actifs de Andrew Smith
| Sociétés | Poste | Début |
|---|---|---|
Sucampo Pharma Europe Ltd.
 Sucampo Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Develops therapies for gastrointestinal, circulatory and ophthalmic diseases | Directeur Financier/CFO | 10/03/2011 |
Sucampo GmbH
 Sucampo GmbH Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals and health care products | Directeur Financier/CFO | 28/06/2012 |
Santhera Pharmaceuticals (USA), Inc.
 Santhera Pharmaceuticals (USA), Inc. Pharmaceuticals: MajorHealth Technology Develops and wholesales medicines for other diseases with high unmet medical needs | Directeur/Membre du Conseil | - |
Arix Bioscience /Venture Capital/
 Arix Bioscience /Venture Capital/ Investment ManagersFinance Arix Bioscience invests in companies located in the United Kingdom. The firm focuses on the therapeutics sector. It participates in early stage capital requirements. | Directeur/Membre du Conseil | 01/08/2022 |
Anciens postes connus de Andrew Smith
| Sociétés | Poste | Fin |
|---|---|---|
| SANTHERA PHARMACEUTICALS HOLDING AG | Directeur Financier/CFO | 24/02/2025 |
| ARIX BIOSCIENCE PLC | Directeur/Membre du Conseil | 01/02/2024 |
Allecra Therapeutics GmbH
 Allecra Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which manufactures pharmaceuticals to combat multi drug-resistant bacterial infections | Directeur Financier/CFO | 01/01/2020 |
| SUCAMPO PHARMACEUTICALS, INC. | Directeur Financier/CFO | 20/03/2017 |
hVIVO Services Ltd.
 hVIVO Services Ltd. Internet Software/ServicesTechnology Services Operates a human-based clinical trial platform to accelerate drug and vaccine development in respiratory and infectious diseases | Directeur Financier/CFO | 01/01/2009 |
Formation de Andrew Smith
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
44
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
1-800 Contacts, Inc.
 1-800 Contacts, Inc. Specialty StoresRetail Trade Sells contact lenses through online | Retail Trade |
Santhera Pharmaceuticals Holding AG
 Santhera Pharmaceuticals Holding AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of neuromuscular diseases | Health Technology |
University of Durham
 University of Durham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sucampo Pharmaceuticals LLC
 Sucampo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures prostone based pharmaceuticals products | Health Technology |
Tech Council of Maryland, Inc.
 Tech Council of Maryland, Inc. Miscellaneous Commercial ServicesCommercial Services Provides membership association services for technology and life science communities | Commercial Services |
Liverpool John Moores University
 Liverpool John Moores University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sucampo Pharma Europe Ltd.
Sucampo Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Develops therapies for gastrointestinal, circulatory and ophthalmic diseases | Commercial Services |
Sucampo GmbH
Sucampo GmbH Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals and health care products | Health Technology |
Clearlab Europe Ltd. | |
hVIVO Services Ltd.
hVIVO Services Ltd. Internet Software/ServicesTechnology Services Operates a human-based clinical trial platform to accelerate drug and vaccine development in respiratory and infectious diseases | Technology Services |
Allecra Therapeutics GmbH
Allecra Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which manufactures pharmaceuticals to combat multi drug-resistant bacterial infections | Health Technology |
Arix Bioscience Plc
 Arix Bioscience Plc Investment ManagersFinance Operates as a global venture capital firm | Finance |
Santhera Pharmaceuticals (USA), Inc.
Santhera Pharmaceuticals (USA), Inc. Pharmaceuticals: MajorHealth Technology Develops and wholesales medicines for other diseases with high unmet medical needs | Health Technology |
Arix Bioscience /Venture Capital/
Arix Bioscience /Venture Capital/ Investment ManagersFinance Arix Bioscience invests in companies located in the United Kingdom. The firm focuses on the therapeutics sector. It participates in early stage capital requirements. | Finance |
